4.5 Article

Perinatal adversities in tuberous sclerosis complex: determinants and neurodevelopmental outcomes

Journal

DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
Volume 64, Issue 10, Pages 1237-1245

Publisher

WILEY
DOI: 10.1111/dmcn.15224

Keywords

-

Funding

  1. Action Medical Research [GN2301]
  2. Autism Speaks [7696]
  3. Tuberous Sclerosis Association
  4. National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London [PB NF-SI-0510-10268]

Ask authors/readers for more resources

The study found that maternal tuberous sclerosis complex (TSC) is a significant marker of increased perinatal risk. However, after controlling for confounders, there was no significant association between perinatal adversities and neurodevelopmental outcomes.
Aim To examine the association between perinatal adversities and neurodevelopmental outcome in tuberous sclerosis complex (TSC). Method The Tuberous Sclerosis 2000 study is a prospective, longitudinal UK study of TSC. In phase 1, mutation type, TSC family history, tuber characteristics, presence of cardiac rhabdomyomas, seizure characteristics, and intellectual ability were assessed in 125 children affected with TSC (64 females, 61 males; median age 39mo, range 4-254). In phase 2, 88 participants (49 females, 39 males; median age 148mo, range 93-323) were assessed for neurodevelopmental outcomes including intellectual ability, autism spectrum disorder, and attention-deficit/hyperactivity disorder. Perinatal histories of 88 participants with TSC and 80 unaffected siblings were collected retrospectively using the Obstetric Enquiry Schedule and coded with a modified Gillberg Optimality Scale to measure levels of perinatal adversity. Data were analysed using Mann-Whitney U tests, Spearman's rank correlation, and linear regression with robust standard errors. Results Children with familial TSC experienced significantly greater perinatal adversity than unaffected siblings. Perinatal adversity was higher in children with TSC-affected mothers than those with unaffected mothers. There was no significant association between perinatal adversities and neurodevelopmental outcomes after controlling for confounders. Interpretation Maternal TSC is a significant marker of elevated perinatal risk in addition to risks incurred by fetal genotype. Pregnancies complicated by maternal or fetal TSC require higher vigilance, and mechanisms underlying increased perinatal adversity require further research.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available